OAS1 and OAS3 Negatively Regulate the Expression of Chemokines and Interferon-Responsive Genes in Human Macrophages
Total Page:16
File Type:pdf, Size:1020Kb

Load more
Recommended publications
-
Transcriptomic Profiling of Equine and Viral Genes in Peripheral Blood
pathogens Article Transcriptomic Profiling of Equine and Viral Genes in Peripheral Blood Mononuclear Cells in Horses during Equine Herpesvirus 1 Infection Lila M. Zarski 1, Patty Sue D. Weber 2, Yao Lee 1 and Gisela Soboll Hussey 1,* 1 Department of Pathobiology and Diagnostic Investigation, Michigan State University, East Lansing, MI 48824, USA; [email protected] (L.M.Z.); [email protected] (Y.L.) 2 Department of Large Animal Clinical Sciences, Michigan State University, East Lansing, MI 48824, USA; [email protected] * Correspondence: [email protected] Abstract: Equine herpesvirus 1 (EHV-1) affects horses worldwide and causes respiratory dis- ease, abortions, and equine herpesvirus myeloencephalopathy (EHM). Following infection, a cell- associated viremia is established in the peripheral blood mononuclear cells (PBMCs). This viremia is essential for transport of EHV-1 to secondary infection sites where subsequent immunopathol- ogy results in diseases such as abortion or EHM. Because of the central role of PBMCs in EHV-1 pathogenesis, our goal was to establish a gene expression analysis of host and equine herpesvirus genes during EHV-1 viremia using RNA sequencing. When comparing transcriptomes of PBMCs during peak viremia to those prior to EHV-1 infection, we found 51 differentially expressed equine genes (48 upregulated and 3 downregulated). After gene ontology analysis, processes such as the interferon defense response, response to chemokines, the complement protein activation cascade, cell adhesion, and coagulation were overrepresented during viremia. Additionally, transcripts for EHV-1, EHV-2, and EHV-5 were identified in pre- and post-EHV-1-infection samples. Looking at Citation: Zarski, L.M.; Weber, P.S.D.; micro RNAs (miRNAs), 278 known equine miRNAs and 855 potentially novel equine miRNAs were Lee, Y.; Soboll Hussey, G. -
A Genetic Variant Protective Against Severe COVID-19 Is Inherited from Neandertals
bioRxiv preprint doi: https://doi.org/10.1101/2020.10.05.327197; this version posted October 9, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. A genetic variant protective against severe COVID-19 is inherited from Neandertals Authors Hugo Zeberg1,2* and Svante Pääbo1,3* Affiliations 1 Max Planck Institute for Evolutionary Anthropology, Deutscher Platz 6, D-04103 Leipzig, Germany. 2 Department of Neuroscience, Karolinska Institutet, SE-17177 Stockholm, Sweden. 3 Okinawa Institute of Science and Technology, Onna-son, Okinawa 904-0495, Japan. *Corresponding authors: [email protected], [email protected] Abstract It was recently shown that the major genetic risk factor associated with becoming severely ill with COVID-19 when infected by SARS-CoV-2 is inherited from Neandertals. Thanks to new genetic association studies additional risk factors are now being discovered. Using data from a recent genome- wide associations from the Genetics of Mortality in Critical Care (GenOMICC) consortium, we show that a haplotype at a region associated with requiring intensive care is inherited from Neandertals. It encodes proteins that activate enzymes that are important during infections with RNA viruses. As compared to the previously described Neandertal risk haplotype, this Neandertal haplotype is protective against severe COVID-19, is of more moderate effect, and is found at substantial frequencies in all regions of the world outside Africa. 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.10.05.327197; this version posted October 9, 2020. -
Environmental Influences on Endothelial Gene Expression
ENDOTHELIAL CELL GENE EXPRESSION John Matthew Jeff Herbert Supervisors: Prof. Roy Bicknell and Dr. Victoria Heath PhD thesis University of Birmingham August 2012 University of Birmingham Research Archive e-theses repository This unpublished thesis/dissertation is copyright of the author and/or third parties. The intellectual property rights of the author or third parties in respect of this work are as defined by The Copyright Designs and Patents Act 1988 or as modified by any successor legislation. Any use made of information contained in this thesis/dissertation must be in accordance with that legislation and must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the permission of the copyright holder. ABSTRACT Tumour angiogenesis is a vital process in the pathology of tumour development and metastasis. Targeting markers of tumour endothelium provide a means of targeted destruction of a tumours oxygen and nutrient supply via destruction of tumour vasculature, which in turn ultimately leads to beneficial consequences to patients. Although current anti -angiogenic and vascular targeting strategies help patients, more potently in combination with chemo therapy, there is still a need for more tumour endothelial marker discoveries as current treatments have cardiovascular and other side effects. For the first time, the analyses of in-vivo biotinylation of an embryonic system is performed to obtain putative vascular targets. Also for the first time, deep sequencing is applied to freshly isolated tumour and normal endothelial cells from lung, colon and bladder tissues for the identification of pan-vascular-targets. Integration of the proteomic, deep sequencing, public cDNA libraries and microarrays, delivers 5,892 putative vascular targets to the science community. -
Oas1b-Dependent Immune Transcriptional Profiles of West Nile
MULTIPARENTAL POPULATIONS Oas1b-dependent Immune Transcriptional Profiles of West Nile Virus Infection in the Collaborative Cross Richard Green,*,† Courtney Wilkins,*,† Sunil Thomas,*,† Aimee Sekine,*,† Duncan M. Hendrick,*,† Kathleen Voss,*,† Renee C. Ireton,*,† Michael Mooney,‡,§ Jennifer T. Go,*,† Gabrielle Choonoo,‡,§ Sophia Jeng,** Fernando Pardo-Manuel de Villena,††,‡‡ Martin T. Ferris,†† Shannon McWeeney,‡,§,** and Michael Gale Jr.*,†,1 *Department of Immunology and †Center for Innate Immunity and Immune Disease (CIIID), University of Washington, § Seattle, Washington 98109, ‡OHSU Knight Cancer Institute, Division of Bioinformatics and Computational Biology, Department of Medical Informatics and Clinical Epidemiology, and **Oregon Clinical and Translational Research Institute, Oregon Health & Science University, Portland, Oregon 97239, ††Department of Genetics and ‡‡Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina 27514 ABSTRACT The oligoadenylate-synthetase (Oas) gene locus provides innate immune resistance to virus KEYWORDS infection. In mouse models, variation in the Oas1b gene influences host susceptibility to flavivirus infection. Oas However, the impact of Oas variation on overall innate immune programming and global gene expression flavivirus among tissues and in different genetic backgrounds has not been defined. We examined how Oas1b acts viral infection in spleen and brain tissue to limit West Nile virus (WNV) susceptibility and disease across a range of innate immunity genetic backgrounds. The laboratory founder strains of the mouse Collaborative Cross (CC) (A/J, C57BL/6J, multiparental 129S1/SvImJ, NOD/ShiLtJ, and NZO/HlLtJ) all encode a truncated, defective Oas1b, whereas the three populations wild-derived inbred founder strains (CAST/EiJ, PWK/PhJ, and WSB/EiJ) encode a full-length OAS1B pro- Multi-parent tein. -
Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase -
(Hies) Infected with Enteric RNA Viruses Identifies Universal and Virus-Specific Epithelial Responses
viruses Article Comparative Analysis of Public RNA-Sequencing Data from Human Intestinal Enteroid (HIEs) Infected with Enteric RNA Viruses Identifies Universal and Virus-Specific Epithelial Responses Roberto J. Cieza 1,2 , Jonathan L. Golob 2, Justin A. Colacino 3,4 and Christiane E. Wobus 1,* 1 Department of Microbiology and Immunology, University of Michigan, Ann Arbor, MI 48109, USA; [email protected] 2 Department of Internal Medicine, Division of Infectious Diseases, University of Michigan Medical School, Ann Arbor, MI 48109, USA; [email protected] 3 Department of Environmental Health Sciences, University of Michigan, Ann Arbor, MI 48109, USA; [email protected] 4 Department of Nutritional Sciences, University of Michigan, Ann Arbor, MI 48109, USA * Correspondence: [email protected] Abstract: Acute gastroenteritis (AGE) has a significant disease burden on society. Noroviruses, rotaviruses, and astroviruses are important viral causes of AGE but are relatively understudied Citation: Cieza, R.J.; Golob, J.L.; enteric pathogens. Recent developments in novel biomimetic human models of enteric disease are Colacino, J.A.; Wobus, C.E. opening new possibilities for studying human-specific host–microbe interactions. Human intestinal Comparative Analysis of Public enteroids (HIE), which are epithelium-only intestinal organoids derived from stem cells isolated from RNA-Sequencing Data from Human human intestinal biopsy tissues, have been successfully used to culture representative norovirus, Intestinal Enteroid (HIEs) Infected rotavirus, and astrovirus strains. Previous studies investigated host–virus interactions at the intestinal with Enteric RNA Viruses Identifies epithelial interface by individually profiling the epithelial transcriptional response to a member of Universal and Virus-Specific each virus family by RNA sequencing (RNA-seq). -
Interferon-Inducible Antiviral Effectors
REVIEWS Interferon-inducible antiviral effectors Anthony J. Sadler and Bryan R. G. Williams Abstract | Since the discovery of interferons (IFNs), considerable progress has been made in describing the nature of the cytokines themselves, the signalling components that direct the cell response and their antiviral activities. Gene targeting studies have distinguished four main effector pathways of the IFN-mediated antiviral response: the Mx GTPase pathway, the 2′,5′-oligoadenylate-synthetase-directed ribonuclease L pathway, the protein kinase R pathway and the ISG15 ubiquitin-like pathway. As discussed in this Review, these effector pathways individually block viral transcription, degrade viral RNA, inhibit translation and modify protein function to control all steps of viral replication. Ongoing research continues to expose additional activities for these effector proteins and has revealed unanticipated functions of the antiviral response. Pattern-recognition Interferon (IFN) was discovered more than 50 years ago in components of the IFNR signalling pathway (STAT1 receptors as an agent that inhibited the replication of influenza (signal transducer and activator of transcription 1), TYK2 (PRRs). Host receptors that can virus1. The IFN family of cytokines is now recognized as (tyrosine kinase 2) or UNC93B) die of viral disease, with sense pathogen-associated a key component of the innate immune response and the the defect in IFNAR (rather than IFNGR) signalling molecular patterns and initiate 6–9 signalling cascades that lead to first line of defence against viral infection. Accordingly, having the more significant role . an innate immune response. IFNs are currently used therapeutically, with the most The binding of type I IFNs to the IFNAR initiates a These can be membrane bound noteworthy example being the treatment of hepatitis C signalling cascade, which leads to the induction of more (such as Toll-like receptors) or virus (HCV) infection, and they are also used against than 300 IFN-stimulated genes (ISGs)10. -
Origin and Development of Oligoadenylate Synthetase Immune System
Edinburgh Research Explorer Origin and development of oligoadenylate synthetase immune system Citation for published version: Hu, J, Wang, X, Yanling , X, Enguang , R, Ning, M, Smith, J & Huang, Y 2018, 'Origin and development of oligoadenylate synthetase immune system', BMC Evolutionary Biology, vol. 18, 201. https://doi.org/10.1186/s12862-018-1315-x Digital Object Identifier (DOI): 10.1186/s12862-018-1315-x Link: Link to publication record in Edinburgh Research Explorer Document Version: Publisher's PDF, also known as Version of record Published In: BMC Evolutionary Biology General rights Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s) and / or other copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated with these rights. Take down policy The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer content complies with UK legislation. If you believe that the public display of this file breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim. Download date: 23. Sep. 2021 Hu et al. BMC Evolutionary Biology (2018) 18:201 https://doi.org/10.1186/s12862-018-1315-x RESEARCH ARTICLE Open Access Origin and development of oligoadenylate synthetase immune system Jiaxiang Hu1†, Xiaoxue Wang1†, Yanling Xing1, Enguang Rong1, Mengfei Ning1, Jacqueline Smith2 and Yinhua Huang1* Abstract Background: Oligoadenylate synthetases (OASs) are widely distributed in Metazoa including sponges, fish, reptiles, birds and mammals and show large variation, with one to twelve members in any given species. -
Interferon-Alpha Immunotherapy of Melanoma: Signal Transduction, Gene Transcription, and the Role of Suppressor of Cytokine Signaling Proteins in Immune Cells
INTERFERON-ALPHA IMMUNOTHERAPY OF MELANOMA: SIGNAL TRANSDUCTION, GENE TRANSCRIPTION, AND THE ROLE OF SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS IN IMMUNE CELLS DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Jason M. Zimmerer, B.S. ***** The Ohio State University 2007 Dissertation Committee: Approved by William E. Carson, III, M.D., Advisor Virginia Sanders, Ph.D. _________________________________ Anne VanBuskirk, Ph.D. Advisor Integrated Biomedical Sciences Mathew Ringel, M.D. Graduate Program i ABSTRACT High dose interferon-alpha-2b (IFN-α-2b) is employed as an adjuvant therapy in melanoma patients who have undergone surgical resection of high-risk lesions. The precise molecular targets of IFN-α therapy are unknown, but likely involve signal transducer and activator of transcription 1 (STAT1) signal transduction within host immune effector cells. We hypothesized that STAT1-mediated signaling induces molecular targets important for mediating the anti-tumor effect of exogenously administered IFN-α. To identify the STAT1-dependent genes, microarray technology was utilized to characterize the gene expression profile of splenocytes from wild type (WT) and STAT1-/- mice stimulated with IFN-α. Analysis showed that 25 genes required STAT1 signal transduction for optimal expression in response to IFN-α (i.e. Gzmb, Isg20, Ly6c; p < 0.001). Interestingly, human immune cells are also capable of inducing the homologues of these genes in response to IFN-α. Human PBMCs, CD3+ T cells, CD56+ natural killer (NK) cells, and CD14+ monocytes each exhibited a distinct and reproducible transcriptional profile following stimulation with IFN-α by microarray analysis. -
An Integrative Multiomics Analysis Identifies Putative Causal Genes For
www.nature.com/gim ARTICLE An integrative multiomics analysis identifies putative causal genes for COVID-19 severity ✉ ✉ Lang Wu1,7 , Jingjing Zhu1,7, Duo Liu1,2, Yanfa Sun1,3,4,5 and Chong Wu6 PURPOSE: It is critical to identify putative causal targets for SARS coronavirus 2, which may guide drug repurposing options to reduce the public health burden of COVID-19. METHODS: We applied complementary methods and multiphased design to pinpoint the most likely causal genes for COVID-19 severity. First, we applied cross-methylome omnibus (CMO) test and leveraged data from the COVID-19 Host Genetics Initiative (HGI) comparing 9,986 hospitalized COVID-19 patients and 1,877,672 population controls. Second, we evaluated associations using the complementary S-PrediXcan method and leveraging blood and lung tissue gene expression prediction models. Third, we assessed associations of the identified genes with another COVID-19 phenotype, comparing very severe respiratory confirmed COVID versus population controls. Finally, we applied a fine-mapping method, fine-mapping of gene sets (FOGS), to prioritize putative causal genes. RESULTS: Through analyses of the COVID-19 HGI using complementary CMO and S-PrediXcan methods along with fine-mapping, XCR1, CCR2, SACM1L, OAS3, NSF, WNT3, NAPSA, and IFNAR2 are identified as putative causal genes for COVID-19 severity. CONCLUSION: We identified eight genes at five genomic loci as putative causal genes for COVID-19 severity. Genetics in Medicine; https://doi.org/10.1038/s41436-021-01243-5 1234567890():,; INTRODUCTION methods, and further apply the gene expression prediction The coronavirus disease 2019 (COVID-19) pandemic represents a models to genome-wide association study (GWAS) data sets of huge public health burden globally. -
Gene Expression Meta-Analysis Reveals Interferon-Induced Genes
bioRxiv preprint doi: https://doi.org/10.1101/2020.11.14.382697; this version posted June 11, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-ND 4.0 International SARS license Gene. Expression Meta-analysis Gene Expression Meta-Analysis Reveals Interferon-induced Genes 1 Amber Park1 and Laura K. Harris1,2* 2 1Davenport University, Harris Interdisciplinary Research, Grand Rapids, MI, USA 3 2Michigan State University, Institute for Cyber-Enabled Research, East Lansing, MI, USA 4 5 * Correspondence: 6 Laura K. Harris 7 [email protected] 8 Keywords: coronavirus, gene expression, meta-analysis, gene set enrichment analysis, GSEA, 9 SARS-CoV, SARS-CoV2. 10 Abstract 11 Background: Severe Acute Respiratory Syndrome (SARS) corona virus (CoV) infections are a 12 serious public health threat because of their pandemic-causing potential. This work analyzes mRNA 13 expression data from SARS infections through meta-analysis of gene signatures, possibly identifying 14 therapeutic targets associated with major SARS infections. 15 Methods: This work defines 37 gene signatures representing SARS-CoV, Middle East Respiratory 16 Syndrome (MERS)-CoV, and SARS-CoV2 infections in human lung cultures and/or mouse lung 17 cultures or samples and compares them through Gene Set Enrichment Analysis (GSEA). To do this, 18 positive and negative infectious clone SARS (icSARS) gene panels are defined from GSEA- 19 identified leading-edge genes between two icSARS-CoV derived signatures, both from human 20 cultures. GSEA then is used to assess enrichment and identify leading-edge icSARS panel genes 21 between icSARS gene panels and 27 other SARS-CoV gene signatures. -
A Genomic Region Associated with Protection Against Severe COVID-19 Is Inherited from Neandertals
A genomic region associated with protection against severe COVID-19 is inherited from Neandertals Hugo Zeberga,b,1 and Svante Pääboa,c,1 aDepartment of Evolutionary Genetics, Max Planck Institute for Evolutionary Anthropology, D-04103 Leipzig, Germany; bDepartment of Neuroscience, Karolinska Institutet, SE-17177 Stockholm, Sweden; and cHuman Evolutionary Genomics Unit, Okinawa Institute of Science and Technology, Okinawa 904-0495, Japan Contributed by Svante Pääbo, January 22, 2021 (sent for review December 21, 2020; reviewed by Tobias L. Lenz and Lluis Quintana-Murci) It was recently shown that the major genetic risk factor associated in Europe, whereas it is almost absent in East Asia. Thus, although with becoming severely ill with COVID-19 when infected by severe this haplotype is detrimental for its carriers during the current acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is inherited pandemic, it may have been beneficial in earlier times in South Asia from Neandertals. New, larger genetic association studies now allow (21), perhaps by conferring protection against other pathogens, additional genetic risk factors to be discovered. Using data from the whereas it may have been eliminated in East Asia by negative Genetics of Mortality in Critical Care (GenOMICC) consortium, we selection. show that a haplotype at a region on chromosome 12 associated with A new study from the Genetic of Mortality in Critical Care requiring intensive care when infected with the virus is inherited from (GenOMICC) consortium, which includes 2,244 critically ill Neandertals. This region encodes proteins that activate enzymes that COVID-19 patients and controls (22), recently became available. are important during infections with RNA viruses.